4.6 Article

A Simple Mycobacterial Monomycolated Glycerol Lipid Has Potent Immunostimulatory Activity

期刊

JOURNAL OF IMMUNOLOGY
卷 182, 期 1, 页码 424-432

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.182.1.424

关键词

-

资金

  1. European Commission [LSHP-CT-2003-503367]
  2. James Bardrick Research Chair and a Royal Society Wolfson Research Merit Award
  3. Medical Research Council (U.K.)
  4. Wellcome Trust
  5. Medical Research Council [G0200510] Funding Source: researchfish
  6. MRC [G0200510] Funding Source: UKRI

向作者/读者索取更多资源

It is a long held belief that the strong immunostimulatory activity of the Mycobacterium bovis bacillus Calmette-Guerin vaccine and Freund's complete adjuvant is due to specific mycobacterial cell envelope components, such as lipids and polysaccharides. Implicated mycobacterial lipids include, among others, the so-called cord factor or trehalose dimycolate, but limited information is available regarding the precise molecular nature of the stimulatory components responsible for the interaction with human APCs. In this regard, the majority of research aimed at identifying and characterizing individual immunostimulatory mycobacterial lipids has been performed in the murine system using bone marrow-derived dendritic cells. In this study, it is documented that potent immunostimulatory activity lies within the bacillus Calmette-Guerin nonpolar lipid class. This activity can be narrowed down to a remarkably simple monomycolyl glycerol (MMG) with the ability to stimulate human dendritic cells as assessed by enhanced expression of activation markers and the release of proinflammatory cytokines. A synthetic analog of MMG based on 32 carbons (C-32) was found to exhibit comparable levels of immunostimulatory activities. Immunization of mice with the tuberculosis vaccine candidate, Ag85B-ESAT-6, in MMG or the synthetic analog using cationic liposomes as the delivery vehicle was found to give rise to a prominent Th1 response characterized by significant levels of IFN-gamma. Together, this development opens up the possibility of producing a novel class of chemically defined lipid adjuvants to enhance the activity of new vaccine formulations, directed against infectious agents including tuberculosis. The Journal of Immunology, 2009, 182: 424-432.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据